Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vadim R. Cherednichenko"'
Autor:
Diana G. Kiseleva, Tatiana V. Kirichenko, Yuliya V. Markina, Vadim R. Cherednichenko, Ekaterina A. Gugueva, Alexander M. Markin
Publikováno v:
Biomedicines, Vol 12, Iss 2, p 465 (2024)
Myocardial edema is the excess accumulation of fluid in the myocardial interstitium or cardiac cells that develops due to changes in capillary permeability, loss of glycocalyx charge, imbalance in lymphatic drainage, or a combination of these factors
Externí odkaz:
https://doaj.org/article/9bcfe64975634a71ac1e686f35dffb2b
Autor:
Yuliya V. Markina, Alexander M. Markin, Tatiana V. Kirichenko, Taisiya V. Tolstik, Vadim R. Cherednichenko, Diana G. Kiseleva, Alexander N. Orekhov
Publikováno v:
Frontiers in Bioscience-Scholar, Vol 15, Iss 4, p 17 (2023)
Background: Mitochondrial dysfunction is considered an important mechanism in the pathogenesis of various diseases. Therefore, mitochondria are currently being considered as subjects for targeted therapies, particularly, phototherapy using 5-aminolev
Externí odkaz:
https://doaj.org/article/2e3ce1c3128a46358eb341214c8e5a40
Autor:
Artem P. Gureev, Victoria G. Khorolskaya, Irina S. Sadovnikova, Ekaterina A. Shaforostova, Vadim R. Cherednichenko, Inna Y. Burakova, Egor Y. Plotnikov, Vasily N. Popov
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 15197
In this research, we compared the cognitive parameters of 2-, 7-, and 15-month-old mice, changes in mitochondrial DNA (mtDNA) integrity and expression of genes involved in the nuclear erythroid 2-related factor 2/antioxidant response element (Nrf2/AR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08b50a750c433d33bb539daacf4a1b80
https://pubmed.ncbi.nlm.nih.gov/36499517
https://pubmed.ncbi.nlm.nih.gov/36499517
Autor:
Yulia I. Kalinina, Vadim R. Cherednichenko, Artem P. Gureev, Irina S. Sadovnikova, Inna Yu. Vitkalova, Ekaterina A. Shaforostova, Vasily N. Popov, Karina A. Reznikova, Valeria V. Valuyskikh
Publikováno v:
Toxicology and Applied Pharmacology. 398:115031
Mildronate is a cardiac and neuroprotective drug that is widely used in some countries. By inhibiting carnitine biosynthesis, mildronate impairs the fatty acids transport into mitochondria, thereby decreasing the β-oxidation intensity. Since 2016, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5e96ace492368855afbebbdea2098b4
https://doi.org/10.1016/j.taap.2020.115031
https://doi.org/10.1016/j.taap.2020.115031